A comparative study of a small series of patients (50 patients) with pelvic varicose veins treated with plugs alone or plugs and polidocanol

De Gregorio, Miguel Ángel (Universidad de Zaragoza) ; Yamamoto-Ramos, Masao ; Fredes, Arturo ; Serrano-Casorran, Carolina (Universidad de Zaragoza) ; Sierre, Sergio ; Ciampi-Dopazo, Juan José ; Méndez, Santiago ; Abadal, Jose Maria ; Urtiaga, Ignacio ; Bonastre, Cristina (Universidad de Zaragoza) ; Rodríguez, Jose ; Urbano, Jose ; Guirola, José Andrés (Universidad de Zaragoza)

Resumen: Level of Evidence: Level 2. Purpose: To compare the safety and efficacy of vascular plug (VP) and vascular plug and polidocanol foam (VPPF) treatments for embolization in pelvic congestion syndrome (PCS). Materials and methods: A comparative, prospective, two-center study enrolled 50 women with PCS from January 2019 to January 2020. The patients were divided into two groups, and embolization was performed with VP (n = 25) and VPPF (n = 25) treatments. The mean age of the patients was 45.6 years ± 6.9. Three clinical parameters were assessed: abdominal pain, dyspareunia, and lower limb pain. The primary outcome (clinical success at 1 yr using a VAS), number of devices, procedure and fluoroscopy times, radiation doses, costs, and complications were compared. The participants were followed-up at 1, 3, 6, and 12 months. Results: At the 1-year follow-up, clinical success did not significantly differ between the two groups (VP vs. VPPF) regarding the improvement of the symptoms analyzed (pelvic pain, dyspareunia, lower extremity pain, and other symptoms (p < 0.05)). The mean number of devices per case was 4 ± 1.1 for the VP group and 2 ± 0.31 for the VPPF group (p < 0.001). No major complications were recorded in either group. The VPPF group had a significantly longer fluoroscopy time (42.8 min ± 14.2 vs. 25.4 min ± 7) and longer radiation dose (VPPF air kerma 839.4 ± 513 vs. VP air kerma 658.4 mGy ± 355 (all p < 0.001)). Conclusions: Embolization for PCS resulted in pain relief in 90% of patients; the use of polidocanol did not demonstrate changes in the clinical outcome. The use of a VP alone was associated with decreased fluoroscopy time and radiation dose.

Idioma: Inglés

DOI: 10.3390/jcm12165408

Año: 2023

Publicado en: Journal of Clinical Medicine 12, 16 (2023), 5408 [12 pp.]
ISSN: 2077-0383

Factor impacto JCR: 3.0 (2023)

Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 59 / 329 = 0.179 (2023) - Q1 - T1

Factor impacto CITESCORE: 5.7 - Medicine (all) (Q1)

Factor impacto SCIMAGO: 0.882 - Medicine (miscellaneous) (Q1)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Radiol. y Medicina Física (Dpto. Microb.Ped.Radio.Sal.Pú.)
Área (Departamento): Área Medicina y Cirugía Animal (Dpto. Patología Animal)